Researchers at Roswell Park Comprehensive Cancer Center are hoping to determine whether genetic profiling may effectively identify which breast cancer patients are most likely to respond to the drug trastuzumab. Preliminary research findings will be summarized by lead investigator Thaer Khoury, MD, FACP, in a presentation on Saturday, June 5, 2010 at the 46th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.

The CEOs of the region’s leading hospital systems and health plans who also represent the founding organizations of HEALTHeLINK, the Western New York Clinical Information Exchange, today launched a month-long drive to increase the number of completed patient consent/election forms.

BUFFALO, NY - About half of all cancer patients with metastatic disease will develop malignant pleural effusions (MPE), which result in significant respiratory challenges and a poorer overall quality of life. A lack of research data has hampered physicians’ efforts to effectively manage MPE.

Surgeon/Engineer Team Produces World's First Procedure-Based Training Software for Robot-Assisted Surgery

BUFFALO, NY — Two Buffalo scientists have paired up to create technology that has the potential to revolutionize surgical training worldwide, developing the first procedure-based, hands-on surgical training software.

BUFFALO, NY — A Buffalo-based international expert on robot-assisted surgical techniques has created the first-ever virtual instructional manual on robot-assisted surgery. The interactive guide, “Operative Manual of Robot-Assisted Urologic Surgery,” edited by Khurshid A.

Buffalo, NY — Men with metastatic prostate cancer who received the new biologic agent tasquinimod (TASQ) saw their progression-free survival time double compared to men who received a placebo, according to initial findings of a phase II clinical study to be presented by Roberto Pili, MD, Profes